Skip to main content
. 2017 Mar 15;8(14):22313–22324. doi: 10.18632/oncotarget.16224

Figure 4. IDA suppressed MTT growth after tail vein injection.

Figure 4

A. Seven mice from each group were subjected to bioluminescence assays before and after treatment. IDA (1 mg/kg per day) was dissolved in 100 μL PBS and injected intraperitoneally for the drug treatment group. Mice from the vehicle group were treated with 100 μL PBS per day. After seven days of treatment, mice were imaged again to measure tumor size. B. Quantification of tumors was analyzed based on whole body bioluminescence signal intensity for each group. Before treatment versus after treatment, *P < 0.05.